MedTrace Logo

Radiographic Influences of Bisphosphonate Treatment on Femur

NCT01969279 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2016-10-19

No results posted yet for this study

Summary

Although there is strong evidence that bisphosphonates prevent certain types of osteoporotic fractures, there are concerns that these medications may be associated with rare atypical femoral fractures (AFF). But the relationship between long-term bisphosphonate treatment and AFF is unclear. In this study, the investigators would like to analyze the long term effects on femur by bisphosphonate treatment.The participants are treated in the investigators hospital more than four years.

Conditions

  • Femur Fracture

Sponsors & Collaborators

  • Tomidahama Hospital

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-10-31
Primary Completion
2017-10-31
Completion
2018-10-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01969279 on ClinicalTrials.gov